MLAB - Mesa Labs Corp Long-Term Indebtedness

Graphic logo of Mesa Laboratories Corp. (MLAB)

Mesa Laboratories, Inc. (MLAB) business is subject to US trade barriers and logistical disruptions in Asia. Revenue stability relies on the constant customer demand for consumables, while long-term debt stands at 0.17. This price chart allows for an assessment of the asset's dynamics. The company's growth is based on the aggressive acquisition of small niche developers and their rapid integration into the overall management structure.

Mesa Labs Corp (MLAB) - Company Long-Term Debt from 07/04/2022 to 10/29/2026

Mesa Labs Corp - analytical breakdowns and key metrics (MLAB)

- market price and analyst price targets:
Stock Price mesalabs.com|MLAB - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Mesa Labs|MLAB - Total Company Value
- company book value details:
Equity per Share Mesa Labs|MLAB - Company Book Value|Market-to-Book Ratio mesalabs.com|MLAB - Aggregate Company Assets
- debt level and financial liquidity data:
Total Debt to Capital Coefficient Mesa Laboratories, Inc.|MLAB - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Mesa Laboratories Corp.|MLAB - Company Aggregate Debts|Debts to Net Assets Mesa Labs|MLAB - Company Long-Term Debts|Company Current Liabilities Mesa Labs|Intermediate Coverage Ratio mesalabs.com
- earnings and valuation multiples indicators:
MLAB - Company Net Income
Summary company analytics:MLAB mesalabs.com
Signature product of Mesa Laboratories Inc

For Mesa Laboratories, Inc. (MLAB), a manufacturer of pharmaceutical equipment, an analysis of the company's long-term debt allows for an assessment of business resilience against geopolitical supply chain disruptions. This metric aggregates all obligations with a maturity of more than one year, reflecting the overall credit load. A decrease in this indicator minimizes default risk, whereas an increase points toward investments in growth. Debt dynamics determine the financial flexibility of Mesa Laboratories, Inc. (MLAB) amid export restrictions.

Who Mesa Laboratories, Inc. competes with

Company Long-Term Debts abbott.com ABT|Thermo Fisher - Company Long-Term Debts|Long-Term Indebtedness GE HealthCare Technologies Inc. (GEHC)|Mettler-Toledo International Inc. (MTD) - Company Long-Term Debt|Company Long-Term Indebtedness WAT|Company Long-Term Debt Bio-Techne Corporation|Long-Term Debt bruker.com BRKR|Company Long-Term Debt Azenta (AZTA)|Long-Term Debt Volume Varex Imaging Corp|Semler Scientific Corp - Company Long-Term Liabilities|Amount of Long-Term Liabilities BFLY (Butterfly Corp)|Quantum-Si - Company Long-Term Debts|Long-Term Debt Volume nanox.vision NNOX|QTRX: Company Long-Term Debts|Company Long-Term Liabilities 908 Devices Inc|Company Long-Term Liabilities CV|MXCT: Company Long-Term Loans and Borrowings|Company Long-Term Debt Rapid Micro Biosystems (RPID)|Company Long-Term Liabilities seer.bio SEER|Company Long-Term Debts HYPR (Hyperfine)|FONAR Corp. (FONR) - Long-Term Debt|Daxor Corp. - Company Long-Term Debts|MDAI (Spectral AI Inc.) - Company Long-Term Indebtedness|VIVS: Company Long-Term Debts|ACON - Long-Term Debt Volume|AKYA (Akoya Biosciences Inc) - Company Long-Term Debts|Company Long-Term Liabilities ThermoGenesis Holdings, Inc. (THMO)|Company Long-Term Debts TLIS|Company Long-Term Debts T2 Biosystems Inc (TTOO)